Grifols Egypt key moments and significant milestones achieved during 2023
Grifols Egypt's key moments during 2023 encapsulate the unwavering commitment and hard work exhibited by GEPD team throughout the year, leading to remarkable accomplishments that set the stage for continued success in the future.
At Grifols Egypt for Plasma Derivatives (GEPD) we are dedicated to enhancing the health and well-being of all Egyptians by providing access to safe and high-quality life saving medicines derived from human plasma.
Plasma derived medicines are unique biological therapies used to treat rare, chronic and, in
some cases, life-threatening diseases.
We are building a national world-class integrated plasma infrastructure that will strengthen the country’s healthcare system.
Latest news
Who we are
Grifols Egypt for Plasma Derivatives is a joint-venture company between Egypt’s National Service Projects Organization (NSPO) and Grifols.
About plasma
Gold-colored plasma is the liquid part of blood and represents about 55% of total blood volume. It contains essential proteins responsible for important life functions, such as immunity and blood coagulation.
Donor Centers
We are glad you are interested in becoming a plasma donor. We look forward to helping you make your vital contribution of plasma.
Careers
Working for Grifols Egypt for Plasma Derivatives is a unique opportunity to take part in a national project directly impacting people’s health and well-being.